TORONTO, ONTARIO--(Marketwired - Nov. 2, 2016) - Mettrum Health Corp. ("Mettrum" or the
"Company") (TSX VENTURE:MT), a vertically integrated provider of cannabis products, is pleased to announce that
it will report its second quarter 2017 financial results for the period ended September 30, 2016, on November 15, 2016 after the
close of market.
About Mettrum Health Corp.
Mettrum Health Corp. is a Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly owned subsidiary of
the Company, is a Toronto-based company and a licensed producer of medical cannabis under the Access to Cannabis for Medical
Purposes Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada) (the "ACMPR"),
which came into effect on August 24th, 2016. Mettrum received its first license from Health Canada under the
Marihuana for Medical Purposes Regulations (the "MMPR") on November 1, 2013 and began production of medical cannabis at
its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on
December 11, 2014 for its other wholly-owned subsidiary, Agripharm Corp., at Mettrum Creemore facility in Clearview, Ontario.
Mettrum received its third license from Health Canada under the MMPR on December 17, 2015 for Mettrum Ltd. at its new 60,000
square foot production and distribution facility in Bowmanville, Ontario. Mettrum is a leading producer and vendor of medical
cannabis under the ACMPR system. In addition, through its wholly-owned subsidiary Mettrum Hempworks, Mettrum also is a
licensed producer and distribution of industrial cannabis (hemp) products, including Mettrum's functional food line, Mettrum
Originals™, under the Industrial Hemp Regulations (Canada) issued pursuant to the Controlled Drugs and Substances
Act (Canada).
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
Exchange) accepts responsibility for the adequacy or accuracy of this Press release.